SAnews.gov.za (Tshwane)

22 October 2012

South Africa: Ground-Breaking SA Discovery Could Be Useful to Produce Aids Vaccine

Photo: Kate Holt/IRIN
File photo: The discovery of the potent antibodies are referred to as broadly “neutralising antibodies” because they kill a wide range of HIV types from different parts of the world. It is largely recognised as being key to finding a vaccine against the virus.

Johannesburg — A ground-breaking discovery by South African scientists, which provides an important new approach that could prove useful in making an Aids vaccine, has been announced.

The Centre for the Aids Programme of Research in South Africa (CAPRISA) on Monday made the announcement of the discovery of a unique feature of HIV that enables infected people to make antibodies that are able to kill a wide range of the HIV strains.

CAPRISA's findings were a proud and great achievement for the country, said Health Minister Aaron Motsoaledi.

An Aids study published in the journal, Nature Medicine, describes how a unique change in the outer covering of the virus found in two HIV infected South African women, enabled them to make potent antibodies which are able to kill up to 88% of HIV types from around the world.

Over the past five years, CAPRISA has been studying how certain HIV infected people develop very powerful antibody responses.

These antibodies are referred to as broadly neutralising antibodies because they kill a wide range of HIV types from different parts of the world.

The CAPRISA team initially discovered that two KwaZulu-Natal women could make these rare antibodies.

Through long term follow-up laboratory studies of the two women, it was discovered that a sugar -known as a glycan - on the surface protein coat of the virus at a specific position (referred to as position 332) forms a site of vulnerability in the virus and enables the body to mount a broadly neutralising antibody response.

"Understanding this elaborate game of 'cat and mouse' between HIV and the immune response of the infected person has provided insights into how broadly neutralising antibodies arise," said Dr Penny Moore of the National Institute for Communicable Disease (NICD).

These were the kind of antibodies that would be needed for a vaccine, she added.

"Up to now, we've known that up to about a fifth of people make those antibodies but we've never known how. We just haven't understood what the process is," she explained.

"What we are showing today is one of the pathways - there are others, but this is one pathway for developing broadly neutralising antibodies.

"The reason it is significant is that it gives us a new way of thinking about how to make a vaccine, which is the next step... It gives us a new strategy that we can exploit, where we try to mimic what happens in infected people but in the absence of the virus and just doing that by vaccination," Moore said.

Head of Aids Research at the NICD Professor Lynn Morris explained that it was a surprise to find that the virus strain which caused infection in many cases did not have this antibody target on its outer covering.

"But over time, the virus was pressured by the body's immune reaction to cover itself with the sugar that formed a point of vulnerability, and so allowed the development of antibodies that hit that weak spot," she said.

Commenting on the significance of the finding, Professor Salim Abdool Karim, director of CAPRISA and President of the Medical Research Council, said that broadly neutralising antibodies were considered to be the key to making an Aids vaccine.

"This discovery provides new clues on how vaccines could be designed to elicit broadly neutralising antibodies. The world needs an effective Aids vaccine to overcome the global scourge of Aids," he added.

Motsoaledi paid tribute to the scientists involved in the study, while highlighting the importance of their finding.

"Our researchers have done us proud. Today's announcement bears testimony to the kind of scientists in our country. Without a doubt, South African scientists are world class scientists," he added.

Government's funding for the study was proof of government's commitment not only to fund treatment but also research to find solutions to the epidemic, Motsoaledi said.

Science and Technology Minister Derek Hanekom, who also applauded the scientists involved in the study, noted that a number of groups, including his department, had co-sponsored the study.

The scientists, among them young and female scientists, were making major breakthroughs in the fight against HIV/Aids and had made the country proud, he added.

Ads by Google

Copyright © 2012 SAnews.gov.za. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.